Natalia López‐Andrés

Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis

Laurent Calvier, María Miana, Pascal Reboul et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2012 · 354 citations

Towards Better Definition, Quantification and Treatment of Fibrosis in Heart Failure. A Scientific Roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology

Rudolf A. de Boer, Gilles W. De Keulenaer, Johann Bauersachs et al. · European Journal of Heart Failure · 2019 · 277 citations · Full text

Association of Galectin-3 and Fibrosis Markers with Long-Term Cardiovascular Outcomes in Patients with Heart Failure, Left Ventricular Dysfunction, and Dyssynchrony: Insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial

Natalia López‐Andrés, Patrick Rossignol, Wafae Iraqi et al. · European Journal of Heart Failure · 2011 · 226 citations

The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries

Laurent Calvier, Ernesto Martínez‐Martínez, María Miana et al. · JACC Heart Failure · 2014 · 206 citations

Hypertension, Heart Failure, Renal Function +12

Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and Hypertension

Ernesto Martínez‐Martínez, Laurent Calvier, Amaya Fernández‐Celis et al. · Hypertension · 2015 · 156 citations · Full text